CAREDX, INC. Cash and Cash Equivalents, Fair Value Disclosure
CAREDX, INC. (CDNA) had Cash and Cash Equivalents, Fair Value Disclosure of $0 as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-07-30
- 2026-06-30: Cash and Cash Equivalents, Fair Value Disclosure $0.00.
- 2026-03-31: Cash and Cash Equivalents, Fair Value Disclosure $14.65M.
- 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure $21.43M.
- 2024-12-31: Cash and Cash Equivalents, Fair Value Disclosure $52.23M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-30 |
| 2026-03-31 | $14.65M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $21.43M 10-Q · filed 2026-07-30 |
| 2024-12-31 | $52.23M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |